Algert Global LLC Has $15.13 Million Stock Position in The New York Times Company $NYT

Core Viewpoint - Algert Global LLC increased its stake in The New York Times Company by 13.3% in Q3, now holding 263,581 shares valued at approximately $15.13 million [2] Institutional Investments - Employees Retirement System of Texas acquired a new stake valued at $28,000 in Q2 [3] - Nomura Asset Management Co. Ltd. raised its position by 86.8% in Q2, now owning 710 shares worth $40,000 [3] - Whittier Trust Co. purchased a new stake worth $42,000 in Q3 [3] - Hantz Financial Services Inc. increased its holdings by 49.4% in Q3, now owning 841 shares valued at $48,000 [3] - Geneos Wealth Management Inc. boosted its position by 690.7% in Q1, now holding 846 shares valued at $42,000 [3] - Institutional investors collectively own 95.37% of the company's stock [3] Insider Transactions - EVP William Bardeen sold 13,000 shares at an average price of $79.56, totaling $1,034,280, reducing his ownership by 41.03% [4] - Chairman Arthur G. Sulzberger sold 13,000 shares at an average price of $79.95, totaling $1,039,350, reducing his ownership by 7.01% [4] - In the last quarter, insiders sold 27,913 shares valued at $2,214,369, with corporate insiders owning 1.90% of the stock [4] Financial Performance - The New York Times reported $0.89 EPS for the last quarter, beating estimates by $0.01, with a net margin of 12.18% and return on equity of 20.73% [6] - Revenue for the quarter was $802.31 million, up 10.4% year-over-year, compared to the consensus estimate of $791.55 million [6] - Analysts forecast an EPS of 2.08 for the current year [6] Dividend Information - The company declared a quarterly dividend of $0.23 per share, up from $0.18, with an annualized dividend of $0.92 and a yield of 1.2% [7] Stock Performance - The New York Times stock opened at $79.30, with a market capitalization of $12.87 billion, a P/E ratio of 37.94, and a beta of 1.09 [5] - The stock has a 1-year low of $44.83 and a high of $82.74 [5] Analyst Ratings - Citigroup lowered its price target from $81.00 to $77.00 while maintaining a "buy" rating [9] - Morgan Stanley set a price objective of $68.00 [9] - Guggenheim set a target price of $63.00 with a "neutral" rating [9] - JPMorgan Chase & Co. raised its target from $71.00 to $74.00 with an "overweight" rating [9] - The average rating for the stock is "Moderate Buy" with a target price of $68.43 [9]